依达拉奉与丁苯酞软胶囊联合应用治疗脑梗死患者的临床效果研究  

Study on clinical effects of Edaravone combined with Butylphthalide soft capsules in treatment of cerebral infarction

作　　者：庄源[1] 徐文丽[1] 安丽荣[1] 魏广宽[1] 

机构地区：[1]黑龙江省医院神经内二科,黑龙江哈尔滨150036

出　　处：《中国民康医学》2016年第9期6-7,共2页Medical Journal of Chinese People’s Health

摘　　要：目的:研究依达拉奉与丁苯酞软胶囊联合应用治疗脑梗死患者的效果。方法:将68例脑梗死患者随机分为观察组和对照组,每组各34例。两组患者均予以常规治疗,对照组患者加用依达拉奉治疗;观察组患者在对照组的基础上加用丁苯酞软胶囊治疗。对比分析两组患者的治疗效果。结果:治疗后,观察组患者的总效率较对照组显著提高(91.18%vs73.53%,P<0.05);治疗后,观察组患者的NIHSS评分显著低于治疗前与对照组治疗后,而BI显著高于治疗前与对照组治疗后(P<0.05)。结论:依达拉奉与丁苯酞软胶囊联合应用于治疗脑梗死能够改善患者的神经功能与生活运动能力,提高其临床疗效,值得推广应用。Objective:To study effects ofEdaravone combined with Butylphthalide soft capsulesin treatment of cerebral infarc-tion. Methods:68 cases of cerebral infarction were randomly divided into observation group and control group,34 cases in each group. Both groups were treated with routine treatment. Besides,the control group was treated with Edaravone,while the observation group was given Edaravone combined with Butylphthalide soft capsules. The effects of the two groups were compared and analyzed. Re-sults:After the treatment,the total effective rate of observation group was significantly higher than that of control group(91. 18%vs73. 53% ,P<0. 05). The NIHSS score after the treatment of observation group was significantly lower than those before the treatment and control group after the treatment;however,the BI was significantly higher than those before the treatment and control group after the treatment(P<0. 05). Conclusions:Edaravone and Butylphthalide soft capsules used in the treatment of cerebral infarction can jointly improve neurological function and exercise capacity of the patients,improve the clinical efficacy,and should be widely applied.

关 键 词：依达拉奉 丁苯酞软胶囊 脑梗死 临床疗效 

分 类 号：R743.3[医药卫生—神经病学与精神病学]